Could a daily aspirin protect diabetic Moms-to-Be?
NCT ID NCT03574909
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether taking low-dose aspirin (150 mg) daily, starting in the first trimester, could reduce pregnancy complications in women with type 1 or type 2 diabetes. The trial included 137 women and looked at outcomes like preeclampsia, early preterm birth, low birth weight, and infant death. The goal was to see if this simple, cheap medicine could improve safety for both mother and baby.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- low-dose aspirin (150 mg prolonged-release capsule)
- What this could lead to
- If it works, this could point toward a simple, low-cost way to lower the risk of serious pregnancy complications like preeclampsia and preterm birth in women with diabetes.
- What could go wrong
- This trial is relatively small (137 participants) and completed, but results may not apply to all women with diabetes. Aspirin also carries a small risk of bleeding or allergic reactions.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRE-GESTATIONAL DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Rotunda Hospital
Dublin, Ireland
More trials for these conditions
Other studies related to the condition(s) this trial covers.